When assessing the association between expression levels for particular genes and patient clinical characteristics, significant differences in ALOX5, HADH, SCD5, SLC44A4, and TRIB3 expression were detected when comparing patients with metastatic and non-metastatic disease (Figure 7I) In addition, differences in DPEP1, HADH, SCD5, SLC44A4, TRIB3, and UGT8 levels were noted among patients with different clinical stages of disease (Figure 7J). The gene discussed is HADH; the disease is metastatic neoplasm.